Histological improvement in chronic hepatitis B patients treated with bicyclol: real world experience

BACKGROUND: Bicyclol, the most commonly-used liver hepatoprotective drug in China, is often selected to control disease progression in CHB patients who refuse anti-viral treatment. However, data on histological changes after bicyclol treatment in these patients are scarce. Therefore, this study has...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi, Xiaoling, Xiao, Huanming, Shi, Meijie, Cai, Gaoshu, Xie, Yubao, Jiang, Junmin, Tian, Guangjun, Wu, Shuduo, Zhang, Chaozhen, Zhao, Pengtao, Chen, Jiezhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567540/
https://www.ncbi.nlm.nih.gov/pubmed/31196030
http://dx.doi.org/10.1186/s12876-019-1005-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567540/
https://www.ncbi.nlm.nih.gov/pubmed/31196030
http://dx.doi.org/10.1186/s12876-019-1005-1

Ejemplares similares